A Reduced-Intensity Conditioning Regimen for Patients with Dyskeratosis Congenita Undergoing Hematopoietic Stem Cell Transplantation

Allogeneic hematopoietic stem cell transplantation (HSCT) is the only curative option for progressive marrow failure, myelodysplastic syndrome, or leukemia associated with dyskeratosis congenita (DC). HSCT for DC is limited by a high incidence of treatment-related mortality, thought to be related to...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Biol Blood Marrow Transplant
Egile Nagusiak: Nelson, Adam S., Marsh, Rebecca A., Myers, Kasiani C., Davies, Stella M., Jodele, Sonata, O’Brien, Tracey A., Mehta, Parinda A.
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: 2016
Gaiak:
Article
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC4826289/
https://ncbi.nlm.nih.gov/pubmed/26845033
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.bbmt.2016.01.026
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak